Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Human embryonic stem cells express an immunogenic nonhuman sialic acid.

Martin MJ, Muotri A, Gage F, Varki A.

Nat Med. 2005 Feb;11(2):228-32. Epub 2005 Jan 30.

PMID:
15685172
2.

Human embryonic stem cells: technological challenges towards therapy.

Oh SK, Choo AB.

Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):489-95. Review.

PMID:
16700884
3.

Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation.

Ghaderi D, Zhang M, Hurtado-Ziola N, Varki A.

Biotechnol Genet Eng Rev. 2012;28:147-75. Review.

PMID:
22616486
4.

The derivation of clinical-grade human embryonic stem cell lines.

Skottman H, Dilber MS, Hovatta O.

FEBS Lett. 2006 May 22;580(12):2875-8. Epub 2006 Apr 7. Review.

5.

N-Glycolylneuraminic acid in human tumours.

Malykh YN, Schauer R, Shaw L.

Biochimie. 2001 Jul;83(7):623-34. Review.

PMID:
11522391
6.

Involvement of a non-human sialic Acid in human cancer.

Samraj AN, Läubli H, Varki N, Varki A.

Front Oncol. 2014 Feb 19;4:33. doi: 10.3389/fonc.2014.00033. eCollection 2014. Review.

7.

The glycans of stem cells.

Lanctot PM, Gage FH, Varki AP.

Curr Opin Chem Biol. 2007 Aug;11(4):373-80. Epub 2007 Jul 27. Review.

8.

Mutation rate in stem cells: an underestimated barrier on the way to therapy.

Sverdlov ED, Mineev K.

Trends Mol Med. 2013 May;19(5):273-80. doi: 10.1016/j.molmed.2013.01.004. Epub 2013 Mar 5. Review.

PMID:
23481596

Supplemental Content

Support Center